Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2013
08/22/2013US20130217670 Quinoxaline derivatives
08/22/2013US20130217669 Azetidinyl diamides as monoacylglycerol lipase inhibitors
08/22/2013US20130217668 Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase
08/22/2013US20130217665 Novel pyrrolidine derivatives
08/22/2013US20130217661 Quinazoline derivatives
08/22/2013US20130217658 Pyrazole compounds acting against allergic, inflammatory and immune disorders
08/21/2013EP2628738A1 Heterocyclic substituted pyridine derivatives and antifungal agent containing same
08/21/2013EP2628729A1 Aromatic heterocyclic derivative, and organic electroluminescent element comprising same
08/21/2013EP2628727A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
08/21/2013EP2628726A1 Hydroxamate-based inhibitors of deacetylases b
08/21/2013EP2628481A1 Trisubstituted heterocycles as replication inhibitors of hepatitis C virus HCV
08/21/2013EP2628389A1 Noxious organism control agent
08/21/2013EP2627649A1 Cxcr4 receptor antagonists
08/21/2013EP2627648A1 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
08/21/2013EP2627637A1 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
08/21/2013EP2627631A1 Pyrrolidinones as metap2 inhibitors
08/21/2013EP2627630A1 Serotonin reuptake inhibitors
08/21/2013EP2627324A2 Substituted benzamides and their uses
08/21/2013EP2627178A1 Quinazolinone-type compounds as crth2 antagonists
08/21/2013CN1976921B Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide
08/21/2013CN1533374B Substitutled cyclohexane-1,4-diamine derivatives
08/21/2013CN103262283A Organic electroluminescent element
08/21/2013CN103261187A Process for preparing tetrazole-ubstituted anthranilamide derivatives and novel crystal polymorph of these derivatives
08/21/2013CN103261186A Dimeric IAP inhibitors
08/21/2013CN103261185A Continuous arycyclic compound
08/21/2013CN103261172A Electronic device including a pyrimidine compound
08/21/2013CN103261167A Substituted 6,6-used nitrogenous heterocyclic compounds and uses thereof
08/21/2013CN103261165A 胰高血糖素受体调节剂 Glucagon receptor modulators
08/21/2013CN103261160A Guanidine compounds and compositions for the inhibition of nampt
08/21/2013CN103261157A Strigolactam derivatives and their use as plant growth regulators
08/21/2013CN103261148A Method for producing and purifying 3-minopropanol
08/21/2013CN103254175A Preparation method of nilotinib
08/21/2013CN103254174A Lansoprazole compound and pharmaceutical composition thereof
08/21/2013CN103254173A Lansoprazole crystal compound
08/21/2013CN103254172A Cytoskeletal active rho kinase inhibitor compounds, composition and use
08/21/2013CN103254171A Aromatic heterocyclic triazine (trans)-delta-farnesene analogue and application thereof
08/21/2013CN103254170A Pyrazole ring-containing pesticide
08/21/2013CN103254125A Pest control agent
08/21/2013CN102127056B Tubulin inhibitors
08/21/2013CN102066359B Novel heteroaryl carboxamide derivatives
08/21/2013CN101981015B 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents
08/21/2013CN101899010B Quinazol derivative, preparation method and application thereof
08/21/2013CN101790517B Inhibitor of binding of s1p1
08/21/2013CN101784533B 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
08/21/2013CN101723933B Piperidine-4-ketone-O-substituted oxime triadimenol-type antifungal compound and preparation method thereof
08/21/2013CN101631785B Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
08/21/2013CN101547915B Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
08/21/2013CN101544592B Process for preparation of N-arylsulfonyl-3-substituted indoles
08/21/2013CN101426779B Pesticides containing a bicyclic bisamide structure
08/21/2013CN101421258B Sulfonyl-substituted bicyclic compounds as modulators of ppar
08/21/2013CN101273028B Macrocyclic inhibitors of hepatitis C virus
08/21/2013CN101193862B Hydroxybenzamide derivatives and their use as inhibitors of HSP90
08/20/2013US8513433 Small molecule inhibitors of PARP activity
08/20/2013US8513427 Compounds for producing substituted sulfoxides, process for producing the same and use thereof
08/20/2013US8513426 Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
08/20/2013US8513423 Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
08/20/2013US8513416 Bisamide-zinc bases
08/20/2013US8513414 Processes and intermediates for producing azaindoles
08/20/2013US8513293 Methods of treating a hyperproliferative disorder or inhibiting cell growth in a mammal
08/20/2013US8513288 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
08/20/2013US8513287 Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same
08/20/2013US8513286 Iminipyridine derivatives and their uses as microbiocides
08/20/2013US8513272 Forms of a fused pyrrolocarbazole compound
08/20/2013US8513268 1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy
08/20/2013US8513267 4-anilinoquinazoline derivatives with adenosine-kinase inhibitor properties
08/20/2013US8513256 Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
08/20/2013US8513255 Substituted dihydroquinazolines
08/20/2013US8513253 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
08/20/2013US8513251 Pyridazinone compounds
08/20/2013US8513244 Neprilysin inhibitors
08/20/2013US8513237 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/20/2013US8513235 Homocysteine synthase inhibitor
08/20/2013US8513232 Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands
08/20/2013US8512878 Diaminopyrene derivative and organic EL device using the same
08/20/2013US8512534 Redox polymers
08/20/2013CA2634232C Method of producing solid preparation disintegrating in the oral cavity
08/20/2013CA2606262C Novel histamine h3-receptor ligands and their therapeutic applications
08/15/2013WO2013119542A1 Compounds for the treatment of hepatitis c
08/15/2013WO2013118071A1 BICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
08/15/2013WO2013117649A1 Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases
08/15/2013WO2013117645A1 Imidazo [4, 5 -c] pyridine derivatives useful for the treatment of degenerative and inflammatory diseases
08/15/2013WO2013117512A1 Novel azetidine derivatives
08/15/2013WO2013117288A1 Tetrahydro-quinazolinone derivatives as tank and parp inhibitors
08/15/2013WO2013096496A3 Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
08/15/2013WO2013062964A3 Methanol derivatives as trpv3 modulators
08/15/2013US20130211079 Substituted heterocycles as therapeutic agents for treating cancer
08/15/2013US20130211076 Method for preparing substituted N-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates N-(3-chloro-quinoxalin-2-yl)-sulfonamides
08/15/2013US20130211075 Amide derivative and use thereof
08/15/2013US20130211047 Purification tags of synthetic peptides and proteins
08/15/2013US20130210858 Sulfamoyl benzoic acid heterobicyclic derivatives as trpm8 antagonists
08/15/2013US20130210847 Process for the preparation of nilotinib
08/15/2013US20130210844 BICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
08/15/2013US20130210829 Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome
08/15/2013US20130210827 Novel benzenesulfonamides as calcium channel blockers
08/15/2013US20130210821 Methods for Treating Obesity
08/15/2013US20130210818 Novel Heterocyclic Compounds and Uses Thereof
08/15/2013US20130210814 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses
08/15/2013US20130210811 Picolinamide and pyrimidine-4-carboxamide compounds, process for preparing and phamaceutical composition comprising the same
08/15/2013US20130210805 Quinazolinone-type compounds as crth2 antagonists
08/15/2013US20130210800 Pyridine-2-derivatives as smoothened receptor modulators
1 ... 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 ... 1080